Clinical Trial Update: A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness [Phase 4]

View source ↗

Summary

Phase 4 study evaluating tear film thickness after switching from preserved prostaglandin formulations to preservative-free tafluprost; the trial status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Tafluprost (tafluprost)

Snippet

Sponsor: Ordination Dr. Hommer | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Status: COMPLETED